[ Back to EurekAlert! ] Public release date: 1-Jun-1999
[ | E-mail | Share Share ]

Contact: Lori Barber
lbarber@ascn.faseb.org
301-530-7038
American Journal of Clinical Nutrition

A new tool in the fight against obesity?

"Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study," by James O. Hill, Jonathan Hauptman, James W. Anderson, Ken Fujioka, Patrick M. O'Neil, Diane K. Smith, James H. Zavoral, and Louis J. Aronne.

Orlistat, a drug that partially blocks the body's absorption of dietary fat, shows promise as a tool to help successful dieters keep weight off, according to the first long-term study of the drug, appearing in June's American Journal of Clinical Nutrition. Two accompanying editorials suggest that orlistat's benefits are modest.

###
For more information about the original research article, contact Dr. Aronne at ljaronne@med.cornell.edu

The two accompanying editorials are: "Is Blockade of Pancreatic Lipase the Answer?" by Charles H. Halsted, Editor-in-Chief of the American Journal of Clinical Nutrition; and "The War against Obesity: Attacking a New Front," by Samuel Klein. Questions about Dr.Halsted's editorial can be sent to him at ajcn@ucdavis.edu; questions about Dr. Klein's editorial can be addressed to sklein@imagate.wustl.edu.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.